Loading...

Verastem, Inc.

VSTMNASDAQ
Healthcare
Biotechnology
$4.87
$0.72(17.28%)

Verastem, Inc. VSTM Peers

See (VSTM) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
VSTM$4.87+17.28%235.7M-1.28-$3.36N/A
VRTX$457.04+2.66%116.1B-117.75-$3.84N/A
REGN$550.36+4.83%56.8B13.59$39.35+0.16%
SGEN$228.74-0.07%43.2B-57.19-$4.00N/A
ALNY$324.40-0.52%42B-152.64-$2.11N/A
ARGX$550.26-0.17%33.1B33.10$16.39N/A
BNTX$107.16+0.64%25.8B-29.37-$3.66N/A
BGNE$184.71+0.49%20.2B-22.55-$8.19N/A
RPRX$36.04+0.01%20.2B14.64$2.45+2.40%
DNA-WT$0.27-2.76%18.7BN/AN/AN/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

VSTM vs VRTX Comparison

VSTM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VSTM stands at 235.7M. In comparison, VRTX has a market cap of 116.1B. Regarding current trading prices, VSTM is priced at $4.87, while VRTX trades at $457.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VSTM currently has a P/E ratio of -1.28, whereas VRTX's P/E ratio is -117.75. In terms of profitability, VSTM's ROE is +58.06%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, VSTM is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for VSTM.

Stock Price Comparison

Loading...

Frequently Asked Questions

;